Through the pioneering Global Health Innovative Technology Fund, homegrown pharmaceutical companies, and global partnerships, Japan has become a leader in the fight against neglected tropical diseases worldwide.
Funding for neglected tropical diseases has declined in the post-pandemic era. But can shifting perspectives and different funding architecture ensure progress continues to be made?
